Status:
COMPLETED
Clinical Observation of Pulsed Dye Laser and Intense Pulsed Light in Treating Facial Telangiectasia
Lead Sponsor:
Xijing Hospital
Conditions:
Telangiectasia
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
1. Facial telangiectasia is one of the common skin vascular lesions characterized by dilated cutaneous vasculatures in the skin surface or mucous membranes. Lesions are generally sensitive to exposure...
Detailed Description
Detailed Description has not been entered.
Eligibility Criteria
Inclusion
- Subjects must be clinically diagnosed with facial telangiectasia
- No other external treatment was performed before the injury was treated
Exclusion
- subjects with a recent history of exposure to sunlight
- subjects allergic to topical anesthesia
- subjects with scar constitution
- subjects with skin malignant tumors or precancerous lesions
- subjects with diabetes, heart disease, epilepsy, connective tissue disease, etc
- subjects who Pregnant or breast feeding
- subjects with recent skin infections (such as viruses, bacteria, etc.)
- other methods are being used to treat subjects with similar diseases
- subject who have taken isotretinoin A in the past year
- subject with facial dermatitis
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04795310
Start Date
January 1 2019
End Date
January 1 2020
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hospital
Xi'an, Shaanxi, China, 710032